FR2384755A1 - Derives de la vitamine d3 ayant une activite antivitamine d - Google Patents
Derives de la vitamine d3 ayant une activite antivitamine dInfo
- Publication number
- FR2384755A1 FR2384755A1 FR7808574A FR7808574A FR2384755A1 FR 2384755 A1 FR2384755 A1 FR 2384755A1 FR 7808574 A FR7808574 A FR 7808574A FR 7808574 A FR7808574 A FR 7808574A FR 2384755 A1 FR2384755 A1 FR 2384755A1
- Authority
- FR
- France
- Prior art keywords
- vitamin
- derivatives
- antivitamin
- activity
- derivatives according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 230000003167 anti-vitamin Effects 0.000 title 1
- 150000003704 vitamin D3 derivatives Chemical class 0.000 title 1
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
- 229940046008 vitamin d Drugs 0.000 abstract 2
- 208000037147 Hypercalcaemia Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 230000002308 calcification Effects 0.000 abstract 1
- 208000022458 calcium metabolism disease Diseases 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 206010020917 hypervitaminosis D Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001394 metastastic effect Effects 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78100877A | 1977-03-24 | 1977-03-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2384755A1 true FR2384755A1 (fr) | 1978-10-20 |
| FR2384755B1 FR2384755B1 (el) | 1983-10-28 |
Family
ID=25121373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7808574A Granted FR2384755A1 (fr) | 1977-03-24 | 1978-03-23 | Derives de la vitamine d3 ayant une activite antivitamine d |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS53119858A (el) |
| DE (1) | DE2812741A1 (el) |
| FR (1) | FR2384755A1 (el) |
| GB (1) | GB1574685A (el) |
| NL (1) | NL7803154A (el) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2426044A2 (fr) * | 1978-05-19 | 1979-12-14 | Wisconsin Research Foundation | Derives de la vitamine d3 ayant une activite anti-vitamine d |
| WO1993021205A1 (en) * | 1992-04-15 | 1993-10-28 | Sri International | Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
| ZA8923B (en) * | 1988-01-20 | 1989-09-27 | Hoffmann La Roche | 16-dehydro-vitamin d3-derivatives |
-
1978
- 1978-03-23 GB GB11797/78A patent/GB1574685A/en not_active Expired
- 1978-03-23 FR FR7808574A patent/FR2384755A1/fr active Granted
- 1978-03-23 DE DE19782812741 patent/DE2812741A1/de active Granted
- 1978-03-23 NL NL7803154A patent/NL7803154A/xx not_active Application Discontinuation
- 1978-03-24 JP JP3319878A patent/JPS53119858A/ja active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2426044A2 (fr) * | 1978-05-19 | 1979-12-14 | Wisconsin Research Foundation | Derives de la vitamine d3 ayant une activite anti-vitamine d |
| WO1993021205A1 (en) * | 1992-04-15 | 1993-10-28 | Sri International | Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
| US5391777A (en) * | 1992-04-15 | 1995-02-21 | Sri International | Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2812741C2 (el) | 1987-03-12 |
| FR2384755B1 (el) | 1983-10-28 |
| NL7803154A (nl) | 1978-09-26 |
| GB1574685A (en) | 1980-09-10 |
| DE2812741A1 (de) | 1978-10-05 |
| JPS53119858A (en) | 1978-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2680366B1 (fr) | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| DE69520656D1 (de) | Beschränkte 9-cis-Retinoide | |
| NO2005018I2 (no) | 2-(2-Nitro-4-trifluormetylbenzoyl) 1,3-cykloheksa ndion eller et salt derav (forkortelse:NTBC) | |
| FR2384755A1 (fr) | Derives de la vitamine d3 ayant une activite antivitamine d | |
| Bueding et al. | Effect of naphthoquinones on Schistosoma mansoni in vitro and in vivo | |
| FR2367750A1 (fr) | Acid | |
| ATE40946T1 (de) | Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. | |
| FR2355807A1 (fr) | Derives d'acides isophtalamiques iodes et agents de contraste qui en contiennent | |
| FR2393579A1 (fr) | Agent antiviral et son application au traitement des affections virales | |
| FR2430402A1 (fr) | Aldehydes a-b-insatures a titre d'ingredients aromatisants | |
| FR2429219A1 (fr) | Medicament a base de derives de la thienopyridone ou de la furopyridone | |
| FR2443464A1 (fr) | Derives d'acides thiadiazole-1,3,4 carboxyliques-2 et produits fongicides et nematicides qui en contiennent | |
| FR2426044A2 (fr) | Derives de la vitamine d3 ayant une activite anti-vitamine d | |
| KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
| FR2395995A1 (fr) | Nouveaux derives d'a-vinylaminoacides, leur preparation et leur utilisation comme inhibiteurs de la decarboxylase des aminoacides aromatiques | |
| TNSN97081A1 (fr) | Inhibition des matrices metalloproteinases par 2- (w-aroylkyl) -4-biaryl-4-des acides oxubutyriques | |
| FR2446286A1 (fr) | Complexes d'allantoine-acide urocanique, insensibles a la lumiere solaire ou a la chaleur, employes dans des formulations de cosmetiques | |
| DE69622005D1 (de) | Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten | |
| FR2357534A1 (fr) | Derives d'acide 2-cyanohexanoique | |
| FR2429017A1 (el) | ||
| SU770494A1 (ru) | Средство, ускоряющее восстановление работоспособности 1 | |
| FR2401133A1 (fr) | Nouveaux derives d'aminoacides a-acetyleniques, leur preparation et leur utilisation comme inhibiteurs de la decarboxylase des aminoacides aromatiques | |
| FR2387652A1 (fr) | Compositions possedant des proprietes curatives anti-coagulantes et anti-tussives | |
| Gaunt et al. | Acute (rat and mouse) and short-term (rat) toxicitystudies on isooctyl isodecyl nylonate | |
| FR2415622A1 (fr) | Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |